Senseonics Holdings (SENS) Total Non-Current Liabilities (2014 - 2025)
Senseonics Holdings' (SENS) quarterly Total Non-Current Liabilities came in at $61.8 million in Q3 2025, up 61.67% year-on-year from $38.2 million in Q3 2024, and up 11.17% on a QoQ basis from $55.6 million in Q2 2025.
Senseonics Holdings (SENS) Total Non-Current Liabilities (2014 - 2025) Analysis & Trends
Senseonics Holdings (SENS) has 12 years of Total Non-Current Liabilities data on file, last reported at $61.8 million in Q3 2025.
- On a quarterly basis, Total Non-Current Liabilities rose 61.67% year-over-year to $61.8 million in Q3 2025; TTM through Sep 2025 was $61.8 million, a 61.67% increase from a year earlier, with the FY2024 full-year figure at $41.7 million, down 35.54% from the prior year.
- Total Non-Current Liabilities for Q3 2025 stood at $61.8 million, up from $55.6 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for SENS reached as high as $485.5 million in Q3 2021 and fell as low as $38.2 million in Q3 2024.
- Historically, Total Non-Current Liabilities has averaged $139.6 million across 5 years, with a median of $64.7 million in 2023.
- Across the five-year window, Total Non-Current Liabilities surged 414.57% in 2021 and slumped 80.4% in 2023, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $315.1 million in 2021, then slumped by 66.69% to $104.9 million in 2022, then sank by 38.38% to $64.7 million in 2023, then sank by 35.54% to $41.7 million in 2024, then soared by 48.17% to $61.8 million in 2025.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $61.8 million in Q3 2025, $55.6 million in Q2 2025, and $46.3 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Senseonics Holdings | 203.54 Mn | 139.22 Mn | 6.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 61.76 Mn |
| Jun 30, 2025 | 55.55 Mn |
| Mar 31, 2025 | 46.35 Mn |
| Dec 31, 2024 | 41.68 Mn |
| Sep 30, 2024 | 38.20 Mn |
| Jun 30, 2024 | 67.32 Mn |
| Mar 31, 2024 | 63.78 Mn |
| Dec 31, 2023 | 64.67 Mn |
| Sep 30, 2023 | 58.03 Mn |
| Jun 30, 2023 | 56.76 Mn |
| Mar 31, 2023 | 54.33 Mn |
| Dec 31, 2022 | 104.94 Mn |
| Sep 30, 2022 | 194.88 Mn |
| Jun 30, 2022 | 104.65 Mn |
| Mar 31, 2022 | 277.23 Mn |
| Dec 31, 2021 | 315.06 Mn |
| Sep 30, 2021 | 485.45 Mn |
| Jun 30, 2021 | 180.39 Mn |
| Mar 31, 2021 | 380.58 Mn |
| Dec 31, 2020 | 115.07 Mn |